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Abstract 
BACKGROUND: One of the typical complaints in females with multiple sclerosis (MS) is Sexual dysfunction (SD).  
AIM: This study aimed to compare the sexual function of women with and without MS and to recognise factors 
that possibly related to sexual dysfunction of women with MS.  
MATERIAL AND METHODS: Sexual function of 64 women with MS as a case study group were compared to a 
group of control comprised of 64 women. Female Sexual Function Inventory (FSFI) and Beck Depression 
Inventory (BDI) were used accordingly to assess sexual function and severity of depression of case and control 
groups. Functional status of MS Patients was assessed by the Expanded Disability Status Scale (EDSS). The 
data were analysed using chi-square, independent Samples t, Pearson's correlation coefficients, and multiple 
linear regression tests.  
RESULTS: There were no differences in the Total FSFI and 4 FSFI subscale scores (i.e. sexual desire, arousal, 
lubrication and satisfaction) between women with MS and controls. The only significant difference between the 
two groups was the dimension of orgasm (p = 0.016). Multivariate analysis demonstrated that only BDI and FSFI 
total scores have significantly related (B = -0.436, P < 0.001). In women with MS, a significant negative correlation 
was found between FSFI and EDSS scores (rho = -0.35, P = 0.032), as well as between FSFI scores and disease 
duration (rho = -0.25, P = 0.01). 
CONCLUSION: Depression was associated to sexual dysfunction in women. It could be advantageous to 
evaluate and treat depression in women with MS who suffer from sexual dysfunction. 
 
 
 
 
 
 
 
 
Introduction 
 
Multiple Sclerosis (MS) is a chronic disease 
caused by autoimmune and inflammatory reactions in 
which nerve fibres are demyelinated in the central 
nervous system [1]. Young people with the ages of 20 
to 40 are most endangered to MS, the ages with most 
sexual activity. Although MS occurs in both sexes, its 
occurrence in females is 2 to 3 times more than in 
males [2]. Disability of MS among adults is common 
[3]. It can negatively affect the physical and mental 
well-being of affected people [4], [5]. The patients with 
MS most often suffer from sexual dysfunction (SD). 
The relationship between MS and sexual dysfunction 
is so complex [6], [7]. It seems that there is a complex 
interaction between social, biological and 
psychological factors which strongly affected by 
'emotions and social competence' of individuals [8]. 
Sexual function is a delicate issue in every culture, 
including Iran. 
In most cases, MS patients are unwilling to 
speak about their sexual problem. As a result, their 
problem remains under-diagnosis. Sexual dysfunction 
caused by MS is more often in women, and its 
prevalence varies from 40% to 80%. According to 
some studies, the most common symptoms of sexual 
dysfunction in women with MS are loss of genital 
sensations, diminished libido, anorgasmia or 
hyporgasmia, and reduction of vaginal lubrication [6], 
[9].  
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The quality of life is affected by the sexual 
function. Thus early diagnosis and intervention of the 
disorder are essential in patients with MS [10]. 
It is estimated that the prevalence rate of MS 
is 45 per 100,000 people in Iran. Within 70% of MS 
patients in Iran are women aged between 20 and 40 
[10]. Due to the religious and culture of Iranian people, 
women tend to conceal their sexual feelings and 
experiences, leading their sexual dysfunction to 
remain unidentified [11]. Sexual dysfunction can lead 
to divorce and family failure [12]. There are several 
studies that investigated the rate of sexual dysfunction 
in Iranian females with MS. Ghajarzadeh (2013) was 
the first who evaluate sexual function in Iranian 
women with MS and reported that the rate of sexual 
dysfunction is 66%. According to Merghati-Khoei 
study, about 87.1% of Iranian women with MS suffer 
from sexual problems [14]. Finally, Mohammadi 
reported that 55.3% of Iranian women with MS has 
sufficient criteria to be classified as sexual dysfunction 
[15].  
Better identifying the MS patients with sexual 
dysfunction as well as determining the associated 
factors requires a better understanding of the 
prevalence and nature of MS to provide therapeutic 
strategies for these patients [16]. 
This study aimed to assess sexual 
dysfunction of women with MS and to compare it with 
a control group of healthy women. Also, possible 
factors associated with sexual dysfunction, including 
depression and demographic variables (age, 
education, employment, marriage duration) are 
examined in this study. 
 
 
Material and Methods 
 
Design and participants of the study 
This comparative case-control analytical study 
was performed from June 2015 to August 2016 on MS 
women who were admitted in hospitals affiliated by 
Islamic Azad University of Mashhad, Iran. The criteria 
for patients to be included in this study were: aged 
between 18 and 50 years, being married, definite MS 
according to MC Donald criteria [17], and having at 
least once sexual intercourse in the last 4 weeks. The 
patients with the following conditions were excluded 
from the study: sexually inactive or postmenopausal 
women, those having had any exacerbations of MS 
during the last 6 months, women with known cases of 
psychiatric disorders, those were under-medicated 
with medicines which could affect sexual activity like 
anti-depressants and beta-blockers, and women with 
other concomitant diseases. Accordingly, 64 women 
were selected as the case group using consecutive 
sampling method. The control group included 64 
healthy women in the same ageing range with the 
case group that were selected from the relatives of 
patients. 
 
Sample size 
From one hand, according to the Ghajarzadeh 
et al., [13], the mean values of general sexual function 
score were 23.2 ± 7.1 and 26.8 ± 5.2 in the case and 
control groups, respectively, and from the other hand, 
considering the coefficient of confidence of 95% and 
the test power of 90%, the least size of 64 were 
considered for each group. 
 
Questionnaires 
To collect demographic data including age, 
marriage duration, employment and educational 
status, a specific checklist was designed. Also, valid 
FSFI questionnaire and a Persian version of Beck 
depression inventory (BDI) were used in this study to 
collect required data. 
FSFI is a self-report questionnaire with 19-
item that is used to evaluate the sexual function of 
women. In addition of a total score of sexual function 
[18], it provides scores of sexual function on six 
domains as follows: desire (2 items, questions 1and 
2), arousal (4 items, questions 3, 4, 5 and 6), 
lubrication (4 items, questions 7, 8, 9 and 10), orgasm 
(3 items, questions 11, 12 and 13), satisfaction (3 
items, questions 14, 15 and 16), and pain (3 items, 
questions 17, 18, 19). According to Wiegel et al., [19], 
to distinguish between women with and without sexual 
dysfunction, an FSFI total score of 26.55 is optimal. 
Mohammadi et al., have well documented the Persian 
version of FSFI and found that the cut-off point for 
FSFI questionnaires is 28 with the sensitivity of 83% 
and specificity of 82%. Accordingly, the FSFI score of 
28 or less is considered to show the sexual 
dysfunction of Iranian women [20].  
The BDI consisted of 21 questions about the 
feelings of respondents over the last week. Each item 
had a score between 0 and 3 that, respondents 
expressed their depression accordingly. The scores of 
all items are added together and Individuals are 
classified as follows: those with a total scores 
between 0 and 9 were identified as not depressed, 
scores between 10 and 18 as mild to moderate 
depression, scores between 19 and 29 as moderate 
to severe depression, and scores between 30 and 63 
as severe depression [21]. The psychometric 
characteristics of the Iranian version of BDI are well 
documented in the literature [22].  
Expanded Disability Status Scale (EDSS) was 
evaluated after a neurological examination of the 
patients, with ranging from 0 to 10 [23]. 
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Analysis 
Data analysis was performed using SPSS 
software V.18.0 (SPSS Inc., Chicago, IL, USA). 
Sample characteristics were examined using 
descriptive statistics such as frequency and mean 
(SD). The data had a normal distribution, so 
Independent Samples t-Test was used to compare 
quantitative variables in two groups of case and 
control. Qualitative variables in the two groups were 
compared using the chi-square test, and the 
relationship between two quantitative variables was 
investigated using the Pearson test. Afterwards, all 
variables were combined into a multiple linear 
regression model. The coefficient of confidence of 
95% was considered in the analysis. 
 
Ethics 
The study had been conducted by the 
Helsinki declaration and approved by the local ethics 
committee. The confidentiality of participants' 
information and their answers to questions were 
assured and written informed consent of all 
participants was taken. 
 
 
Results 
 
The numbers of patients with MS and healthy 
participants in the study was 64 in each group. Ninety 
four per cent (60 patients) of MS patients suffer from 
relapsing-remitting MS, and other 6 per cent (4 
patients) had secondary progressive MS. The results 
of the comparison between cases and control group 
are presented in Table 1. As it could be seen from this 
table, the median of EDSS is 2 with a range from 0 to 
6 and the mean duration of the disease is equal to 
52.5 months (ranging from 6 to 84.5). 
Table 1: Comparison of personal properties in cases and 
controls groups 
 
Quantitative variables 
Cases 
Mean (SD) 
Controls 
Mean (SD) 
Statistic 
p-value 
Age (years) 35.25 (8.07) 32.83 (8.07) t=1.697 
P =0.092 
Marriage duration (years) 13.17 (8.77) 10.58 (8.60) T = 1.683 
P =0.095 
 
Qualitative variables 
Cases 
No. (%) 
Controls 
No. (%) 
Statistic 
P -value 
 
Employment  
Non-employed 60 (93.8%) 17(26.6%) Pearson Chi-
Square = 60.268 
P = 0.000 
Employed 4(6.2%) 47(73.4%) 
 
Education  
Primary -
secondary 
43 (67.2%) 19(29.7%) Pearson Chi-
Square = 18.018 
P = 0.000 Higher 21(39.8%) 45(70.3%) 
 
It could be seen from the table 1 that mean 
age (p = 0.092) and marriage duration (p = 0.095) of 
two groups are not significantly different. However, 
there is a significant difference in employment (p < 
0.001) and educational level (p < 0.001) of the two 
groups. Table 2 shows the comparison of BDI score 
and total score of sexual dysfunction and its 
subscales between the case and control groups. 
Table 2: Mean BDI, the total score of sexual dysfunction and its 
subscales in case and control groups 
 MS Patients 
Mean (SD) 
Controls 
Mean (SD) 
statistics P -value 
BDI 18.92 (10.81) 9.93 (7.46) T = 5.467 P < 0.001* 
Total score of 
sexual dysfunction 
22.86 (5.36) 24.39 (4.75) T = -1.714 P = 0.089 
Desire  3.26 (1.11) 3.50 (1.02) T = -1.297 P = 0.197 
Arousal  3.43 (1.22) 3.81 (1.12) T = -1.814 P = 0.072 
Lubrication  5.76 (1.40) 6.20 (1.41) T = -1.730 P = 0.086 
Orgasm  3.81 (1.26) 4.29 (0.96) T = -1.730 P = 0.016** 
Satisfaction  3.71 (1.39) 3.85 (0.94) T = -0.683 P = 0.496 
Dyspareunia  2.67 (1.01) 2.75 (0.98) T = -0.426 P = 0.671 
* Significant at P < 0.001; ** Significant at P < 0.01. 
 
According to Table 2, the total score of sexual 
function is not significantly different between the two 
groups. Among the items of the questionnaire, orgasm 
is the only item that has a significant difference in the 
two groups (p = 0.016), and the value of mean score 
for orgasm is better in control group in comparison 
with the patient group. The obtained score of 
depression in the case group is significantly higher 
than the score in the control group (p = 0.000).  
Univariate analysis was firstly conducted to 
investigate the relationship between variables of age, 
marriage duration, depression, education and 
employment using total score of sexual function. The 
results are presented in Table 3. From the results 
shown in Table 3, it could be seen that age and 
depression are only items with a significant 
relationship in terms of the total score of sexual 
function.  
Table 3: Univariate analysis results and risk factors for sexual 
dysfunction 
Independent Variables  Statistic P-value 
Multiple sclerosis a T = -1.714 0.089 
Depression inventory of Beck b R = -.411 P < 0.001** 
Age b R = -.0181 0.041* 
Education a T = -1.563 0.121 
Employment a T = -1.027 0.306 
Marriage duration b R = -0.167 0.06 
Dependent Variable: Total score of FSFI; a conducted using independent sample t-test; b 
conducted using Pearson's correlation test; * Significant at P < 0.05; ** Significant at P < 
0.001. 
 
Afterwards, all variables used in univariate 
analysis were combined into a multiple linear 
regression model. The results are indicated in Table 
4. It is seen from this table that, there is only a 
significant relationship between the BDI and FSFI total 
scores.  
Table 4: The results of multivariable linear regression analysis 
and risk factors for sexual dysfunction 
Variables  B SE Beta t P-value 
Multiple sclerosis  0.156 1.207 0.015 .129 0.897 
Beck depression 
inventory  
-0.216 0.048 -0.436 -4.474 < 0.001* 
Age  -0.035 0.103 -0.056 -0.341 0.737 
Education  -0.851 1.193 -0.084 -0.713 0.477 
Employment -0.699 1.321 -0.067 -0.529 0.598 
Marriage duration  -0.055 0.103 -0.094 -0.528 0.598 
Dependent Variable: Total score of FSFI; * Significant at P < 0.001. 
 
Univariate analyses of Pearson's and 
independent sample t-tests were used to examine the 
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relationship between sexual dysfunction subscales 
and independent variables. The obtained results are 
given in Table 5. 
Table 5: The results of univariate analyses for the relationship 
between sexual dysfunction subscales and other variables 
 BDI 
(r, P value) 
Age 
(r, P value) 
Marriage 
duration 
(r, P value) 
Employment 
(t, P value) 
Education 
(t, P value) 
Desire  (-0.377,0.000***)a (-0.184,0.037*)a (-0.215,0.015*)a (-1.255,0.212)b (-1.573,0.118)b 
Arousal  (-0.440,0.000***)a (-0.173,0.051)a (0.210,0.017*)a (-1.579,0.117)b (-2.085,0.039**)b 
Lubrication  (-0.306, 0.000***)a (-.0183,0.038*)a (-0.120,0.176)a (-1.067,0.288)b (-0.975,0.332)b 
Orgasm  (-0.453,0.000***)a (-0.183,0.039*)a (-0.180,0.042*)a (-1.429,0.156)b (-2.962,0.004**)b 
Satisfaction  (-0.356,0.000***)a (-0.137,0.124)a (-0.195,0.027*)a (-0.393,0.695)b (-2.526,0.013**)b 
Dyspareuni
a  
(0.067,0.647)a (0.044,0.621)a (0.90,0.310)a (-0.496,0.621)b 0.751,0.454)b 
a: performed using Pearson's correlation test; b: performed using independent sample t test; * Significant at 
P < 0.05; ** Significant at P < 0.01; *** Significant at P < 0.001.  
 
The results of multivariate analysis 
represented a significant relationship between 
depression and all other sexual function subscales (p 
< 0.001) except for dyspareunia.  
Different scores in patients with and without 
sexual dysfunction are shown in Table 6. As could be 
seen in this table, there is a significant difference 
between patients who have a total FSFI score higher 
than 28 and those with a score lower than 28 in terms 
of mean BDI and all subscales of FSFI except for 
dyspareunia. 
Table 6: Total FSFI scores of patients with and without sexual 
dysfunction 
 
 
Patients with 
FSFI < 28 
N = 53 
Mean (SD) 
Patients with FSFI 
> 28 
N = 11 
Mean (SD) 
Statistic P values 
BDI 20.9 (10.33) 9.45 (7.9) T = 5.467 P = 0.001 
Total sexual score 21.22 (4.25) 30.75 (2.16) T = -1.714 P < 0.001 
Desire  2.96 (0.89) 4.69 (0.96) T = -1.297 P < 0.001 
Arousal  3.08 (0.96) 5.1 (0.9) T = -1.814 P < 0.001 
Lubrication  5.45 (1.28) 7.27 (0.93) T = -1.730 P < 0.001 
Orgasm  3.50 (1.08) 5.3 (0.95) T = -1.730 P < 0.001 
Satisfaction  3.39 (1.24) 5.23 (1.06) T = -0.683 P < 0.001 
Dyspareunia  2.77 (1.05) 2.21 (0.63) T = -0.426 P = 0.1 
 
There are significant negative correlations 
between disease duration and FSFI scores (rho = -
0.25, P = 0.01) and between EDSS and FSFI scores 
(rho = -0.35, P = 0.032) in MS patients. Also, a 
significant positive correlation could be seen between 
EDSS and BDI (rho = 0.31, P < 0.001) in the patients. 
Around 12.5 per cent of patients in the case 
group (eight people) and 4.7 per cent in the control 
group (three people) answered “Yes” to this question 
that "Have physicians and medical staff ever asked 
about your sexual problems?", that in this regard 
didn't exist a significant difference between the two 
groups. (p = 0.26)  
 
 
Discussion 
 
Sexual dysfunction is one of the common side 
effects of multiple sclerosis (MS) that usually goes 
unreported by patients and do not address by 
clinicians [16]. The prevalence of sexual dysfunction 
in MS patients had been estimated to be between 
40% and 80 % [24]. 
The aim of this study was to investigate the 
prevalence of sexual dysfunction in MS patients and 
to recognize factors that possibly related to sexual 
dysfunction of women with MS. considering a cut-off 
point of 28 on the FSFI in this study, high prevalence 
of sexual dysfunction (82.5%) was found that is 
consistent with the previous research. In his study, 
Ghajarzadeh (2013) considering a cut-off point of 
26.55 for FSFI, reported that the prevalence of sexual 
dysfunction in Iranian MS women are 66% [13]. 
Mohammadi [15] considered a cut-off point of 28 for 
FSFI and found a high frequency of sexual 
dysfunction among Iranian women with MS (55.3%). 
In their study on the sexual problem of Iranian women 
with MS, Merghati-Khoei et al., [14] based on Multiple 
Sclerosis Intimacy and Sexuality Questionnaire-19 
(MSISQ-19) reported that 87.1% of women with MS 
had a primary sexual problem.  
To compare the sexual function of MS 
patients with healthy people, a control group 
consisting of 64 healthy women was selected in our 
study. As far as we know, the only research amongst 
Iranian studies on MS women that used a control 
group is Ghajarzadeh study [13]. 
Anyhow, regarding all subscales and total 
score of FSFI in our study, the mean scores for the 
case group were worse than the control. According to 
our study results, there are no statistical differences 
between the two groups except for orgasm. This is not 
consistent with Ghajarzadeh study, in which 
significant differences between the scores of two 
groups were found. This disagreement may be 
caused by different sample sizes used in the two 
studies. In the Ghajarzadeh study, the case group 
consisted of 100 patients and the control group 
including 50 women [13], while in our study, the 
numbers of people in both groups were 64. The 
members of the control group in our study were 
selected amongst patients` relatives, and this may be 
another reason for the difference between the two 
studies. Various socio-cultural spheres have different 
sexual behaviour [25]. As a result, individuals of a 
family because of they're common sociocultural have 
close sexual function. As mentioned previously, the 
orgasm was the only item that differed between the 
case and control groups. This is consistent with 
Merghati-Khoei et al., [14] who found that the most 
frequent symptom of primary sexual problems in MS 
women is delayed orgasm (75.7%). Ashtari et al., [10] 
in their study about sexual dysfunctions among 
Iranian women showed that orgasmic problems are 
the most common sexual dysfunction with 41.2% 
prevalence in Iranian women. 
Marriage duration had no relationship with 
sexual function in this study. Contrarily, Merghati-
Khoei et al. found an inverse relationship between 
sexual problems and marriage duration. They 
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attributed this inverse relationship to change in 
perceptions and problem discounting that exist as 
sexual frequency has declined over time [14].  
There was also no significant relationship 
between age and sexual function in the present study. 
Although, univariate analysis identified age as a 
significant factor (Table 1), but its effect reduced when 
multiple linear regression analysis was performed. 
Similar results are reported by Ghajarzadeh [13] and 
Mohammadi [15]. Also, Khan et al., [24] using Sexual 
Frequency Scale found no relationship between age 
and sexual dysfunction. In the other hand, Merghati-
Khoei has reported a significant positive relationship 
between age and sexual problems [14]. This could be 
attributed to the different questionnaire (MSISQ-19) as 
well as using the univariate analysis in Merghati-Khoei 
study.  
One of the predominant psychological 
problems that can influence sexual dysfunction in MS 
patients is depression. Depression is more common in 
MS patients [25], [26], [27], so it seems logical to 
expect that these patients suffer from sexual 
dysfunction more than others. In the present study, 
the mean BDI score in MS patients was significantly 
higher than in the control group. In both the overall 
score and the subscale scores, mean BDI was the 
only predictor of FSFI score, except for dyspareunia. 
Similarly, there are many studies that reported a 
strong relationship between depression and sexual 
dysfunction [15], [30]. [31], [32] In their study, 
Ghajarzadeh et al., reported a negative and significant 
correlation between the total score of sexual 
dysfunction and BDI score in MS patients [13]. 
According to ELIXIR study, 76 per cent of depressed 
participants suffer from arousal problems, and the 
other 24 per cent had problems with erectile or 
lubrication [33]. Physiological and psychological 
factors can cause depression symptoms in MS 
patients that require close monitoring and selecting 
appropriate treatment options such as behavioural 
and pharmacological approaches) [34]. Furthermore, 
using antidepressants by depressed patients may 
worsen the sexual dysfunction in them, as studies 
have confirmed the relation between antidepressants 
and sexual dysfunction [35], [36].  
The relationship between sexual dysfunction 
and employment and education wasn't significant in 
this study. This is not in line with some studies [14], 
[38], but is consistent with the results of Redelman 
study [35]. 
The results of our study showed a significant 
difference between patients with and without sexual 
dysfunction (patients with FSFI score of less and more 
than 28) in terms of mean total FSFI scores and its 
subscales. These results are in line with the findings 
of Ghazarzadeh et al., [13], and Lombardi et al., [39]. 
This study has some limitations. First, the 
collection of data and samples were only done in one 
outpatient centre. When generalising the results of 
this study to whole Iranian MS women, one should 
notice this limitation. Second, the information on the 
spouses of the understudy patients was not collected. 
Future studies must address this issue. 
In conclusion, the results of this study showed 
a significant relationship between depression and 
sexual dysfunction in MS population. As a result, it is 
helpful to evaluate and treat depression in patients 
with MS who suffer from sexual dysfunction as a 
starting point for intervention. The ideal is that 
physicians make it a part of their daily assessment. 
However, many physicians and health care providers 
do not spend enough time or have not convenience to 
talk about sexual issues of their patients, and many of 
them do not have enough education about treatment 
of sexual dysfunction [34]. 
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